Explore & understand different types of pain and mechanism of actions to advance novel & patient-centric approaches to pain drug development
Assess current pain therapeutics as a catalyst for better pain R&D with case studies from Caventure Drug Discovery, Inc., Rottapharm Biotech & University of Michigan
Discover novel analgesic targets from latest pre-clinical approaches to novel pain drugs development with solution led talks delivered by leading biotechs and academics such as Carica Health, Anavex Life Sciences & Saint Louis University
Through case studies and deep discussions with key experts from NIH, McGill University & Northeastern University benchmark and overcome key translational challenges such as lack of predictability of models, biomarker identification and clinical design of novel pain drug development
Find out about the most innovative approaches of pain drugs currently in clinical development from leaders such as Mesoblast, Chromocell, AcheBlios Therapeutics & Indiana University
Wyndham Boston Beacon Hill
5 Blossom St
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.